The Epigenetic promise for prostate cancer diagnosis

Evidence of Heavy Methylation in the Galectin 3 Promoter in Early Stages of Prostate Adenocarcinoma: Development and Validation of a Methylated Marker for Early Diagnosis of Prostate Cancer

(2014) Hafiz Ahmed et al.   Translational Oncology

Tumour markers in prostate cancer III: Biomarkers in urine

(2011) Monique J. Roobol et al.   ACTA ONCOLOGICA

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis

(2011) T Wu et al.   BRITISH JOURNAL OF CANCER

Epigenetic Deregulation Across Chromosome 2q14.2 Differentiates Normal from Prostate Cancer and Provides a Regional Panel of Novel DNA Methylation Cancer Biomarkers

(2011) J. Devaney et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer

(2011) Joo Mi Yi et al.   CLINICAL CANCER RESEARCH

The Science and Art of Prostate Cancer Screening

(2011) Siu-Long Yao et al.   JNCI-Journal of the National Cancer Institute

An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection

(2011) Andrew J. Vickers et al.   JNCI-Journal of the National Cancer Institute

Clinical Evaluation of the PCA3 Assay in Guiding Initial Biopsy Decisions

(2011) Alexandre de la Taille et al.   JOURNAL OF UROLOGY

Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA

(2011) S. A. Tomlins et al.   Science Translational Medicine

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

(2010) R C Macefield et al.   BRITISH JOURNAL OF CANCER

American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010

(2010) A. M. D. Wolf et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Detection of TMPRSS2 Gene Deletions and Translocations in Carcinoma, Intraepithelial Neoplasia, and Normal Epithelium of the Prostate by Direct Fluorescence In Situ Hybridization

(2010) Shengle Zhang et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome

(2010) Marco Auprich et al.   EUROPEAN UROLOGY

The Impact of Prostate Biopsy and Periprostatic Nerve Block on Erectile and Voiding Function: A Prospective Study

(2010) Tobias Klein et al.   JOURNAL OF UROLOGY

PCA3 Molecular Urine Test for Predicting Repeat Prostate Biopsy Outcome in Populations at Risk: Validation in the Placebo Arm of the Dutasteride REDUCE Trial

(2010) Sheila M.J. Aubin et al.   JOURNAL OF UROLOGY

Gene Promoter Methylation and Its Potential Relevance in Early Prostate Cancer Diagnosis

(2010) Isabel Steiner et al.   PATHOBIOLOGY

Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARβ2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens

(2009) Gerald Zon et al.   ANALYTICAL BIOCHEMISTRY

Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive Biopsies

(2009) D. A. Troyer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Promoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients

(2009) Lorenzo Richiardi et al.   JOURNAL OF CLINICAL ONCOLOGY

Serial Prostate Biopsies are Associated With an Increased Risk of Erectile Dysfunction in Men With Prostate Cancer on Active Surveillance

(2009) Kazutoshi Fujita et al.   JOURNAL OF UROLOGY

Prostate Specific Antigen Best Practice Statement: 2009 Update

(2009) Kirsten L. Greene et al.   JOURNAL OF UROLOGY

ETS gene fusions in prostate cancer

(2009) Jeremy P. Clark et al.   Nature Reviews Urology

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

(2008) Alexander Haese et al.   EUROPEAN UROLOGY

The Performance of Prostate Specific Antigen for Predicting Prostate Cancer is Maintained After a Prior Negative Prostate Biopsy

(2008) Ian M. Thompson et al.   JOURNAL OF UROLOGY

Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis

(2008) Timothy A Chan et al.   PLOS MEDICINE